Desonide Ointment has an estimated market size of USD 13 million for 12 months ending December 2018, according to IQVIA.
Shares of Alembic Pharmaceuticals rose nearly 2 percent intraday on October 24 after the company's joint venture received USFDA approval for Desonide Ointment.
The company's joint venture Aleor Dermaceuticals has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Desonide Ointment, 0.05%, as per BSE release.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Ointment, 0.05%, of Perrigo New York, Inc, company added.
Desonide Ointment is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Desonide Ointment has an estimated market size of $13 million for 12 months ending December 2018, according to IQVIA.
The company has a cumulative total of 105 ANDA approvals (93 final approvals and 12 tentative approvals) from USFDA.At 1022 hrs, Alembic Pharmaceuticals was quoting at Rs 545.50, up Rs 8.30, or 1.55 percent on the BSE.Are you happy with your current monthly income? Do you know you can double it without working extra hours or asking for a raise? Rahul Shah, one of the India's leading expert on wealth building, has created a strategy which makes it possible... in just a short few years. You can know his secrets in his FREE video series airing between 12th to 17th December. You can reserve your free seat here.